Novo Nordisk’s Triple Bottom Line Yields Shared Value
Assessing and communicating how a Triple Bottom Line business principle delivers value to business and society.
(3BL Media) June 1, 2012 - In the company’s fourth Blueprint for Change case study, Novo Nordisk provides evidence that its Triple Bottom Line business approach has resulted in higher quality and access to diabetes treatment in Bangladesh.
The Blueprint for Change case study on Bangladesh concludes by stating the opportunities and challenges of using a similar Triple Bottom Line approach to address access in other least developed countries. Findings include the positive correlation between investing start-up capital in sustainable medical education programmes and the corresponding improvement in treatment outcomes and quality of care. Additionally, the case study highlights the shared value of a partnership approach, including improved accessibility and affordability of treatment, strengthened reputational value and increased sales volume.
Download the Blueprint for Change: Changing Diabetes in Bangladesh
About the Blueprint for Change Programme
The Novo Nordisk Blueprint for Change Programme aims to assess and communicate how a Triple Bottom Line business principle delivers value to business and society. Each of the four Blueprint for Change case studies present models of sustainable business practices and help identify key challenges ahead.
For more information, please visit: http://novonordisk.com/sustainability/How-we-manage/blueprints.asp
About Sustainability at Novo Nordisk
Novo Nordisk strives to conduct its activities in a financially, environmentally and socially responsible way. The strategic commitment to corporate sustainability has brought the company onto centre stage as a leading player in today’s business environment, recognised for its integrated reporting, stakeholder engagement and consistently high sustainability performance. In 2012, Novo Nordisk received the top ranking on Corporate Knight’s list of Global 100 Most Sustainable Corporations. Novo Nordisk is listed in the 2010/2011 Dow Jones Sustainability Indices with a gold class rating. For more information, visit novonordisk.com/sustainability
Further information:
